Skip to content
Open access

Cell-type-specific damage scores reveal kidney and liver disease trajectories in single-cell and spatial transcriptomics

Aug 2026 · Cell Genomics · Vol 6, pp. 101337 · 1 citation · 196 references
Medicine

TL;DR

A generalizable single-cell and spatial transcriptomics framework that quantifies continuous damage trajectories in vivo using cell-type-specific scores that enable scalable mapping of degenerative disease progression and stage-specific therapeutic targets is introduced.

Abstract

Summary Degenerative diseases progress through gradual cell-intrinsic damage that is difficult to resolve with bulk transcriptomics or discrete cell-state analysis. We introduce a generalizable single-cell and spatial transcriptomics framework that quantifies continuous damage trajectories in vivo using cell-type-specific scores. Applied to chronic kidney disease and metabolic dysfunction-associated steatotic liver disease, the podocyte damage score (PDS) and hepatocyte damage score (HDS) place individual podocytes and hepatocytes on a health-to-damage axis. Across mouse and human single-cell RNA sequencing (scRNA-seq), single-nucleus RNA-seq (snRNA-seq), spatial transcriptomics, proteomics, histology, and clinical datasets, PDS and HDS robustly detect disease-associated damage, align disease models as well as unperturbed cells, and reveal conserved pathways. The PDS links podocyte injury and FSGS progression to circadian gene-expression disruption. The HDS identifies a damage threshold in metabolic dysfunction-associated steatotic liver disease (MASLD)/NASH beyond which hepatocytes adopt senescent, metabolically dysfunctional states. These damage scores enable scalable mapping of degenerative disease progression and stage-specific therapeutic targets.

Read PDF

Similar papers

Review Open access Oct 2026

Mechanistic insights and translational perspectives on liver fibrosis through single-cell transcriptomics

Liver fibrosis is a defining feature of chronic liver diseases and can progress to cirrhosis and liver failure. Single-cell RNA sequencing (scRNA-seq) enables high-resolution analysis of cellular heterogeneity and multicellular interactions during fibrogenesis. In this narrative review, we analyzed published single-cel...

Wei-Wei Lu, Jun Xu, Ke-Xin Wang et al. · 0 citations
Review Sep 2026

Single-cell and spatial transcriptomics inform mechanistic physiology in non-model animals

This review provides a physiology-centered blueprint for applying single-cell RNA sequencing, single-nucleus RNA sequencing, and spatial transcriptomics to non-model species and critically evaluates dissociation and preservation bias, genome annotation, seasonal and ecological variation, biological replication, pseudor...

Adnan Amin, W. Zaman · 0 citations
Review Open access Sep 2026

Single-cell and single-nucleus transcriptomics in ischemic stroke: cellular mechanisms and therapeutic implications

This review systematically integrates current evidence from sc/snRNA-seq studies, with a primary focus on brain-intrinsic mechanisms after ischemic stroke, to provide a structured synthesis of how sc/snRNA-seq has advanced the understanding of ischemic stroke biology.

Chang-Qing Mu, Yu-Chuan Ding, Alexander Weiss et al. · 0 citations
Open access Nov 2026

Clinical, single-cell, and spatial transcriptomic integration identifies an RCD-high inflammatory myeloid program for early neurological deterioration and outcome stratification after acute ischemic stroke

Neuroinflammation and regulated cell death (RCD) are important components of secondary injury after acute ischemic stroke (AIS). However, the myeloid cell states involved in these processes and their spatial organization within ischemic brain tissue remain incompletely understood. This study aimed to characterize R...

Nan Jia, Jian-Qiao Li, He Yang et al. · 0 citations
Open access Oct 2026

Spatial and single-nucleus transcriptomics reveals the molecular pathology of type 2 diabetes-associated cognitive dysfunction.

The mechanisms underlying type 2 diabetes-associated cognitive dysfunction (DACD) remain poorly understood, hindering therapeutic progress. Here, we integrated spatial transcriptomics and single-nucleus RNA sequencing to delineate the spatiotemporal molecular and cellular landscape of DACD in brain tissues from 3- and...

Wei Wu, Yu-Meng Yang, Xi-Xi Zhang et al. · 0 citations
Open access Oct 2026

Multiscale transcriptomic network models of Parkinson’s disease at the single-cell level

An integrative, meta-cell based multiscale network analysis of snRNA-seq data from the substantia nigra to systematically uncover molecular mechanisms and identify potential therapeutic targets for Parkinson's Disease is developed.

Linh Chu, Ge-Fei Yu, Xian-Xiao Zhou et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.